Luke Lango is pitching the OpenAI Mega-IPO as the biggest pre-IPO opportunity of the decade. The hook: a publicly traded stock under $10 that gives you backdoor exposure to OpenAI before it goes public.

The vehicle is Innovation Investor, his flagship monthly newsletter at InvestorPlace. First year costs $49. After that it renews at $199. The newsletter and the thesis behind it sit at the intersection of Lango’s documented track record, the OpenAI IPO timeline, and a marketing layer that highlights the best picks.

What Innovation Investor Actually Is

Innovation Investor is Lango’s core newsletter product. Monthly issues, model portfolio, buy and sell alerts, and access to the research behind his thesis calls.

The content focus is technology megatrends with an early-stage bias. Lango looks for the companies that sit at the intersection of a structural trend and an inflection point — the kind of pick that could go up 10X if the thesis plays out and 0X if it does not.

The OpenAI Mega-IPO is the current front-door pitch for new subscribers. The claim is that one stock under $10 in his portfolio owns a meaningful stake in OpenAI that the market is not pricing correctly. If OpenAI goes public — and the speculation is that it could be the largest IPO in stock market history — that stake becomes worth multiples of where it trades today.

He also includes SpaceX and Anduril pre-IPO exposure reports as bonus research for new subscribers.

The Track Record Behind the Thesis

Lango was ranked the #1 stock picker in the world by TipRanks in 2020 at age 25 — 81% success rate across 503 recommendations with a 35.1% average return per pick. The ranking is independently verifiable, not a marketing claim.

According to InvestorPlace’s published track record, Lango’s documented winners include AMD at +8,000%, Nvidia at +5,000%, Tesla at +3,500%, and Shopify at +1,400%. These are calls with public entry points that predated mainstream coverage. Past performance does not guarantee future results.

Innovation Investor reports an average return of 102% across all picks since inception. That number comes from InvestorPlace and reflects the full model portfolio. The 30+ ten-bagger claim — stocks that went up 10X or more from his entry — is cited across his marketing materials and the named examples are verifiable through public price data.

What the $49 First Year Gets You

The first-year pricing is clearly promotional. $49 for a monthly newsletter with model portfolio and trade alerts is at the low end of the newsletter space, where comparable products from Stansberry or Mauldin Economics run $100-$200 per year.

The catch is the renewal price. At $199, Innovation Investor is in line with competing products from the same publisher. The 90-day money-back guarantee means you can test the service for three months and walk away if the thesis is not landing for you.

The real cost consideration is the implicit cost of acting on picks that may require patience. Pre-IPO exposure plays are inherently speculative. The underlying stock could trade sideways for quarters while the IPO narrative develops. If the IPO never materializes — or values OpenAI below the implied thesis — the stock could reprice lower.

The Under-$10 Stock Thesis

The specific stock behind the OpenAI Mega-IPO thesis is not named in the marketing. That is standard for the newsletter industry — the reveal is reserved for paid subscribers, which is how the product converts free traffic into revenue.

What can be evaluated is the structural logic. A publicly traded company with a material OpenAI stake, trading under $10, that the market has not fully revalued for that exposure. The asymmetry is real: a binary option on the OpenAI IPO at a single-digit stock price with the rest of the business providing a floor. The thesis depends on the IPO materializing at a valuation that lifts the underlying stake — and the closer OpenAI gets to a public listing, the more the market re-prices the exposure.

The structural question is how much of that revaluation is already baked in. A stock under $10 with an OpenAI stake is trading where it is because the market has not yet fully connected the dots. That gap is the opportunity Lango is identifying.

How It Compares to Other Lango Products

Innovation Investor sits between his free content and his premium offering. The free Hypergrowth Investing articles on InvestorPlace give you the thesis direction. Innovation Investor gives you the specific picks. Early Stage Investor at $1,799 gives you the venture-stage, 10X-or-bust ideas.

For a reader evaluating the OpenAI Mega-IPO pitch, Innovation Investor is the middle option. It is priced to be an easy entry point, with a clear thesis and a defined timeline. If you want Lango’s best ideas across multiple time horizons, Early Stage Investor is the fuller product. If you want to test his methodology on one specific thesis, Innovation Investor at $49 is the lower-commitment path.

The Full Picture

Lango brings a documented track record with independently verifiable winners — the TipRanks ranking is public and the named picks come with priced, dated entries attached to them. His methodology — quantimental analysis combining AI-driven screening with fundamental judgment — is transparent enough to follow and apply.

The return figures in the marketing material highlight the best picks, which is standard for any investment newsletter. The full model portfolio at InvestorPlace includes the complete set of positions and outcomes. The OpenAI IPO timeline is the key variable — the thesis depends on an event that moves on its own schedule, and the closer that event gets, the more the underlying thesis compounds. The broader AI stock-picker convergence of summer 2026 — Lango alongside Navellier, Green, and others — is the publisher context the OpenAI Mega-IPO pitch sits inside.

Where This Fits

Innovation Investor at $49 is the entry tier of Lango’s product lineup. Right for a reader who wants Lango’s specific stock picks across technology megatrends without the $1,799 commitment of Early Stage Investor, and who accepts that pre-IPO exposure plays are inherently speculative with timelines that move on their own schedule. Wrong for a reader who wants the venture-stage, 10X-or-bust ideas (that is Early Stage Investor) or who needs the methodology direction without paying for picks (that is the free Hypergrowth Investing articles).

Our default: Innovation Investor is the right product for a reader who has evaluated Lango’s methodology through his free InvestorPlace articles, wants to test his picks on a single thesis like the OpenAI Mega-IPO, and wants the 90-day money-back guarantee as the structural feature that makes the $49 first-year commitment an informed one. The under-$10 stock is one piece of a broader research package that spans pre-IPO exposure, SpaceX, and Anduril. More newsletter and service reviews are collected at the Newsletter Reviews hub. Past performance does not guarantee future results.